Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 4 filers reported holding Santen Pharmaceutical Co Ltd in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $335,000 | +15.1% | 17,780 | +4.2% | 0.04% | -11.1% |
| Q3 2019 | $291,000 | +18.8% | 17,058 | +12.0% | 0.04% | +15.4% |
| Q2 2019 | $245,000 | +188.2% | 15,237 | +149.1% | 0.04% | +160.0% |
| Q1 2019 | $85,000 | -2.3% | 6,116 | -6.5% | 0.02% | -34.8% |
| Q4 2018 | $87,000 | +163.6% | 6,542 | +174.4% | 0.02% | +155.6% |
| Q3 2018 | $33,000 | -8.3% | 2,384 | +2.6% | 0.01% | -30.8% |
| Q2 2018 | $36,000 | +5.9% | 2,323 | 0.0% | 0.01% | +8.3% |
| Q1 2018 | $34,000 | +3.0% | 2,323 | 0.0% | 0.01% | -7.7% |
| Q4 2017 | $33,000 | 0.0% | 2,323 | 0.0% | 0.01% | -7.1% |
| Q3 2017 | $33,000 | +22.2% | 2,323 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $27,000 | -10.0% | 2,323 | -2.9% | 0.01% | -7.7% |
| Q1 2017 | $30,000 | +500.0% | 2,392 | +304.1% | 0.01% | +333.3% |
| Q4 2016 | $5,000 | +66.7% | 592 | +141.6% | 0.00% | +50.0% |
| Q3 2016 | $3,000 | +200.0% | 245 | +255.1% | 0.00% | +100.0% |
| Q2 2016 | $1,000 | – | 69 | +25.5% | 0.00% | – |
| Q1 2016 | $0 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | $273 | 0.00% |